BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$629M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$380M |
| 3 |
Apple
AAPL
|
+$369M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$226M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$161M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.69B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$893M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$361M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$321M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$148M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 9.47% |
| 4 | Financials | 9.13% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Outlook Therapeutics
OTLK
$50.2M
| $26.4K | ﹤0.01% |
1,292
+821
| +174% | +$16.7K |
|
2852
Soleno Therapeutics
SLNO
$3.02B
| $25.9K | ﹤0.01% |
9,335
| – | – |
|
|
CWBC
2853
Community West Bancshares
CWBC
$404M
| $25.5K | ﹤0.01% |
1,762
+1,504
| +583% | +$21.8K |
|
|
HARP
2854
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $24.8K | ﹤0.01% |
1,299
+1,106
| +573% | +$21.1K |
|
2855
KB Financial Group
KB
$30.6B
| $24.8K | ﹤0.01% |
666
+41
| +7% | +$1.53K |
|
|
SPPI
2856
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $24.7K | ﹤0.01% |
31,652
+16,460
| +108% | +$12.8K |
|
|
MBII
2857
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $24.4K | ﹤0.01% |
21,060
+12,127
| +136% | +$14.1K |
|
2858
Carisma Therapeutics
CARM
$15.7M
| $24.4K | ﹤0.01% |
1,507
-768
| -34% | -$12.4K |
|
2859
FirstService
FSV
$9.51B
| $24.4K | ﹤0.01% |
+201
| New | +$24.4K |
|
2860
Verrica Pharmaceuticals
VRCA
$46.5M
| $24.3K | ﹤0.01% |
1,268
+1,148
| +957% | +$22K |
|
|
SBT
2861
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $23.5K | ﹤0.01% |
4,118
+4,110
| +51,375% | +$23.4K |
|
2862
NVE Corp
NVEC
$326M
| $23.3K | ﹤0.01% |
500
+73
| +17% | +$3.4K |
|
2863
Biglari Holdings Class B
BH
$977M
| $23.2K | ﹤0.01% |
189
-780
| -80% | -$95.7K |
|
2864
Carlyle Secured Lending
CGBD
$999M
| $22.8K | ﹤0.01% |
1,799
-1,954
| -52% | -$24.8K |
|
2865
KALA BIO
KALA
$119M
| $22.6K | ﹤0.01% |
1,508
+1,402
| +1,323% | +$21K |
|
2866
First Northwest Bancorp
FNWB
$62.3M
| $22.2K | ﹤0.01% |
+1,421
| New | +$22.2K |
|
2867
NL Industries
NL
$301M
| $22.1K | ﹤0.01% |
2,236
+757
| +51% | +$7.47K |
|
2868
Applied Therapeutics
APLT
$62.9M
| $21.8K | ﹤0.01% |
22,954
+21,415
| +1,391% | +$20.3K |
|
2869
Global X US Infrastructure Development ETF
PAVE
$9.48B
| $21.4K | ﹤0.01% |
941
+606
| +181% | +$13.8K |
|
2870
DURECT Corp
DRRX
$59.3M
| $20.9K | ﹤0.01% |
4,378
+2,119
| +94% | +$10.1K |
|
2871
Citius Pharmaceuticals
CTXR
$20.6M
| $20.4K | ﹤0.01% |
885
+331
| +60% | +$7.62K |
|
|
CEQP
2872
DELISTED
Crestwood Equity Partners LP
CEQP
| $20.2K | ﹤0.01% |
838
-210,433
| -100% | -$5.07M |
|
2873
Clearside Biomedical
CLSD
$27.4M
| $20.2K | ﹤0.01% |
13,712
-911
| -6% | -$1.34K |
|
2874
Spero Therapeutics
SPRO
$111M
| $20.1K | ﹤0.01% |
27,176
+24,668
| +984% | +$18.3K |
|
2875
Northrim BanCorp
NRIM
$511M
| $20.1K | ﹤0.01% |
500
-1,016
| -67% | -$40.9K |
|